We are live on
!
Find out more
Pacira BioSciences
PCRX
PCRX
241 hedge funds and large institutions have $986M invested in Pacira BioSciences in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 91 increasing their positions, 82 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
61% more call options, than puts
Call options by funds: $477K | Put options by funds: $296K
11% more repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 82
1.47% less ownership
Funds ownership: 109.11% → 107.65% (-1.5%)
7% less funds holding
Funds holding: 260 → 241 (-19)
19% less capital invested
Capital invested by funds: $1.21B → $986M (-$229M)
30% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 43
Holders
241
Holders Change
-19
Holders Change %
-7.31%
% of All Funds
2.97%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
30
Increased
91
Reduced
82
Closed
43
Calls
$477K
Puts
$296K
Net Calls
+$181K
Net Calls Change
-$1.69M
Top Buyers
| 1 |
EF
Empowered Funds
Havertown,
Pennsylvania
|
+$6.15M |
| 2 |
Goldman Sachs
New York
|
+$5.99M |
| 3 |
Morgan Stanley
New York
|
+$4.44M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$4.38M |
| 5 |
BCC
Bridge City Capital
Lake Oswego,
Oregon
|
+$2.61M |
